N-Cyclopentyl-2′-C-methyladenosine, identified by its CAS number 205171-06-8, is a modified nucleoside that exhibits unique structural and functional characteristics. This compound features a cyclopentyl group attached to the nitrogen atom at the 9-position of the adenine base, along with a methyl group at the 2′ position of the ribose sugar. These modifications enhance its stability and bioavailability compared to unmodified adenosine. N-Cyclopentyl-2′-C-methyladenosine is known for its potential therapeutic applications, particularly in the field of pharmacology, where it may act as an agonist or antagonist at adenosine receptors. Its structural modifications can influence its interaction with biological targets, making it a subject of interest in drug development. Additionally, the compound's solubility and permeability properties are often evaluated to determine its suitability for various biological assays and therapeutic uses. Overall, N-Cyclopentyl-2′-C-methyladenosine represents a significant advancement in the design of nucleoside analogs with enhanced pharmacological profiles.

N-Cyclopentyl-2′-C-methyladenosine

205171-06-8: N-Cyclopentyl-2′-C-methyladenosine, Adenosine, N-cyclopentyl-2′-C-methyl-

N-Cyclopentyl-2''-C-methyl-adenosine

Adenosine, N-cyclopentyl-2'-C-methyl-

N6-Cyclopentyl-2'-C-methyl-adenosine is an antiviral agent that inhibits the synthesis of DNA by preventing the formation of RNA from DNA. It has been shown to be effective against HIV and other retroviruses. N6-Cyclopentyl-2'-C-methyl-adenosine is a synthetic nucleoside that is activated by phosphorylation in cells, which leads to the synthesis of monophosphate (5'-AMP). This compound is used for the treatment of cancer and HIV infection.

CAS 205171-06-8: N-Cyclopentyl-2′-C-methyladenosine

N-Cyclopentyl-2''-C-methyl-adenosine

Ref: 7W-GN1996

Adenosine, N-cyclopentyl-2'-C-methyl-

Ref: IN-DA0029X3

N6-Cyclopentyl-2'-C-methyl-adenosine

Ref: 3D-NC14080